Search - tctmd.com

Displaying 1 - 20 of 257

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

Michael O'Riordan

January 28, 2026

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

TCTMD’s Biggest News of 2025

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

TCTMD’s Top 10 Most Popular Stories for December 2025

What’s Going to Be Hot at AHA 2025?

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

What’s Going to Be Hot at TCT 2025

Risk Factors Present in Nearly All Patients Who Develop CVD

TCTMD’s Top 10 Most Popular Stories for September 2025

CVD Still the Leading Cause of Death and Disease Globally

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

What’s Going to Be Hot at ESC Congress 2025?

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

TCTMD’s Top 10 Most Popular Stories for June 2025

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content